Loading…
Glycyrrhizic acid derivatives as Dengue virus inhibitors
[Display omitted] •It is the first report to display structure-anti-DENV activity relationships of Glycyrrhizic acid (GL) derivatives.•GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 have been identified as potent DENV2 inhibitors.•GL derivatives 13 and 17 showed lower IC50 values (1...
Saved in:
Published in: | Bioorganic & medicinal chemistry letters 2019-10, Vol.29 (20), p.126645-126645, Article 126645 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c455t-25980d0bee0435991b55aa9a858bf079cb4259463787ef7791052cb2dea98e8d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c455t-25980d0bee0435991b55aa9a858bf079cb4259463787ef7791052cb2dea98e8d3 |
container_end_page | 126645 |
container_issue | 20 |
container_start_page | 126645 |
container_title | Bioorganic & medicinal chemistry letters |
container_volume | 29 |
creator | Baltina, Lidia A. Tasi, Yan-Ting Huang, Su-Hua Lai, Hsueh-Chou Baltina, Lia A. Petrova, Svetlana F. Yunusov, Marat S. Lin, Cheng-Wen |
description | [Display omitted]
•It is the first report to display structure-anti-DENV activity relationships of Glycyrrhizic acid (GL) derivatives.•GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 have been identified as potent DENV2 inhibitors.•GL derivatives 13 and 17 showed lower IC50 values (1.2–1.3 μM) against DENV2 infectivity in Vero E6 cells than GL (IC50 8.1 μM).
Dengue virus (DENV) is one of the most geographically distributed pathogenic flaviviruses transmitted by mosquitoes Aedes sps. In this study, the structure-antiviral activity relationships of Glycyrrhizic acid (GL) derivatives was evaluated by the inhibitory assays on the cytopathic effect (CPE) and viral infectivity of DENV type 2 (DENV2) in Vero E6 cells. GL (96% purity) had a low cytotoxicity to Vero E6 cells, inhibited DENV2-induced CPE, and reduced the DENV-2 infectivity with the IC50 of 8.1 μM. Conjugation of GL with amino acids or their methyl esters and the introduction of aromatic acylhydrazide residues into the carbohydrate part strongly influenced on the antiviral activity. Among compounds tested GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 were found as potent anti-DENV2 inhibitors (IC50 1.2–1.3 μM). Therefore, modification of GL is a perspective way in the search of new antivirals against DENV2 infection. |
doi_str_mv | 10.1016/j.bmcl.2019.126645 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7172207</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X19305906</els_id><sourcerecordid>2290839986</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-25980d0bee0435991b55aa9a858bf079cb4259463787ef7791052cb2dea98e8d3</originalsourceid><addsrcrecordid>eNp9kMFq3DAQhkVJaTZpX6CH4GMu3oxkyZIgFMqm3RQCvSTQm5Dl2d1ZvHYq2YbN09fLJqG55DSH-f5_ho-xrxzmHHh5tZ1Xu9DMBXA756IspfrAZlyWMi8kqBM2A1tCbqz8c8rOUtoCcAlSfmKnBVfcFlrNmFk2-7CPcUNPFDIfqM5qjDT6nkZMmU_ZDbbrAbOR4pAyajdUUd_F9Jl9XPkm4Zfnec4efv64X9zmd7-Xvxbf7_IglepzoayBGipEkIWylldKeW-9UaZagbahkhMiy0IbjSutLQclQiVq9NagqYtz9u3Y-zhUO6wDtn30jXuMtPNx7zpP7u2mpY1bd6PTXAsBeiq4fC6I3d8BU-92lAI2jW-xG5ITwoIprDXlhIojGmKXUsTV6xkO7qDcbd1BuTsod0flU-ji_wdfIy-OJ-D6COCkaSSMLgXCNmBNEUPv6o7e6_8HYgOS9A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2290839986</pqid></control><display><type>article</type><title>Glycyrrhizic acid derivatives as Dengue virus inhibitors</title><source>ScienceDirect Journals</source><creator>Baltina, Lidia A. ; Tasi, Yan-Ting ; Huang, Su-Hua ; Lai, Hsueh-Chou ; Baltina, Lia A. ; Petrova, Svetlana F. ; Yunusov, Marat S. ; Lin, Cheng-Wen</creator><creatorcontrib>Baltina, Lidia A. ; Tasi, Yan-Ting ; Huang, Su-Hua ; Lai, Hsueh-Chou ; Baltina, Lia A. ; Petrova, Svetlana F. ; Yunusov, Marat S. ; Lin, Cheng-Wen</creatorcontrib><description>[Display omitted]
•It is the first report to display structure-anti-DENV activity relationships of Glycyrrhizic acid (GL) derivatives.•GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 have been identified as potent DENV2 inhibitors.•GL derivatives 13 and 17 showed lower IC50 values (1.2–1.3 μM) against DENV2 infectivity in Vero E6 cells than GL (IC50 8.1 μM).
Dengue virus (DENV) is one of the most geographically distributed pathogenic flaviviruses transmitted by mosquitoes Aedes sps. In this study, the structure-antiviral activity relationships of Glycyrrhizic acid (GL) derivatives was evaluated by the inhibitory assays on the cytopathic effect (CPE) and viral infectivity of DENV type 2 (DENV2) in Vero E6 cells. GL (96% purity) had a low cytotoxicity to Vero E6 cells, inhibited DENV2-induced CPE, and reduced the DENV-2 infectivity with the IC50 of 8.1 μM. Conjugation of GL with amino acids or their methyl esters and the introduction of aromatic acylhydrazide residues into the carbohydrate part strongly influenced on the antiviral activity. Among compounds tested GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 were found as potent anti-DENV2 inhibitors (IC50 1.2–1.3 μM). Therefore, modification of GL is a perspective way in the search of new antivirals against DENV2 infection.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2019.126645</identifier><identifier>PMID: 31519375</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Anti-Inflammatory Agents - chemistry ; Anti-Inflammatory Agents - pharmacology ; Antiviral activity ; Antiviral Agents - chemistry ; Antiviral Agents - pharmacology ; Cell Survival - drug effects ; Chlorocebus aethiops ; Cytopathogenic Effect, Viral - drug effects ; Dengue - drug therapy ; Dengue virus ; Dengue Virus - drug effects ; Derivatives ; Glycyrrhizic acid ; Glycyrrhizic Acid - analogs & derivatives ; Glycyrrhizic Acid - chemistry ; Glycyrrhizic Acid - pharmacology ; Humans ; Molecular Structure ; Small Molecule Libraries - chemistry ; Small Molecule Libraries - pharmacology ; Structure-Activity Relationship ; Vero Cells - drug effects ; Virus Replication - drug effects</subject><ispartof>Bioorganic & medicinal chemistry letters, 2019-10, Vol.29 (20), p.126645-126645, Article 126645</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><rights>2019 Elsevier Ltd. All rights reserved. 2019 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-25980d0bee0435991b55aa9a858bf079cb4259463787ef7791052cb2dea98e8d3</citedby><cites>FETCH-LOGICAL-c455t-25980d0bee0435991b55aa9a858bf079cb4259463787ef7791052cb2dea98e8d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31519375$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baltina, Lidia A.</creatorcontrib><creatorcontrib>Tasi, Yan-Ting</creatorcontrib><creatorcontrib>Huang, Su-Hua</creatorcontrib><creatorcontrib>Lai, Hsueh-Chou</creatorcontrib><creatorcontrib>Baltina, Lia A.</creatorcontrib><creatorcontrib>Petrova, Svetlana F.</creatorcontrib><creatorcontrib>Yunusov, Marat S.</creatorcontrib><creatorcontrib>Lin, Cheng-Wen</creatorcontrib><title>Glycyrrhizic acid derivatives as Dengue virus inhibitors</title><title>Bioorganic & medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>[Display omitted]
•It is the first report to display structure-anti-DENV activity relationships of Glycyrrhizic acid (GL) derivatives.•GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 have been identified as potent DENV2 inhibitors.•GL derivatives 13 and 17 showed lower IC50 values (1.2–1.3 μM) against DENV2 infectivity in Vero E6 cells than GL (IC50 8.1 μM).
Dengue virus (DENV) is one of the most geographically distributed pathogenic flaviviruses transmitted by mosquitoes Aedes sps. In this study, the structure-antiviral activity relationships of Glycyrrhizic acid (GL) derivatives was evaluated by the inhibitory assays on the cytopathic effect (CPE) and viral infectivity of DENV type 2 (DENV2) in Vero E6 cells. GL (96% purity) had a low cytotoxicity to Vero E6 cells, inhibited DENV2-induced CPE, and reduced the DENV-2 infectivity with the IC50 of 8.1 μM. Conjugation of GL with amino acids or their methyl esters and the introduction of aromatic acylhydrazide residues into the carbohydrate part strongly influenced on the antiviral activity. Among compounds tested GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 were found as potent anti-DENV2 inhibitors (IC50 1.2–1.3 μM). Therefore, modification of GL is a perspective way in the search of new antivirals against DENV2 infection.</description><subject>Animals</subject><subject>Anti-Inflammatory Agents - chemistry</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Antiviral activity</subject><subject>Antiviral Agents - chemistry</subject><subject>Antiviral Agents - pharmacology</subject><subject>Cell Survival - drug effects</subject><subject>Chlorocebus aethiops</subject><subject>Cytopathogenic Effect, Viral - drug effects</subject><subject>Dengue - drug therapy</subject><subject>Dengue virus</subject><subject>Dengue Virus - drug effects</subject><subject>Derivatives</subject><subject>Glycyrrhizic acid</subject><subject>Glycyrrhizic Acid - analogs & derivatives</subject><subject>Glycyrrhizic Acid - chemistry</subject><subject>Glycyrrhizic Acid - pharmacology</subject><subject>Humans</subject><subject>Molecular Structure</subject><subject>Small Molecule Libraries - chemistry</subject><subject>Small Molecule Libraries - pharmacology</subject><subject>Structure-Activity Relationship</subject><subject>Vero Cells - drug effects</subject><subject>Virus Replication - drug effects</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kMFq3DAQhkVJaTZpX6CH4GMu3oxkyZIgFMqm3RQCvSTQm5Dl2d1ZvHYq2YbN09fLJqG55DSH-f5_ho-xrxzmHHh5tZ1Xu9DMBXA756IspfrAZlyWMi8kqBM2A1tCbqz8c8rOUtoCcAlSfmKnBVfcFlrNmFk2-7CPcUNPFDIfqM5qjDT6nkZMmU_ZDbbrAbOR4pAyajdUUd_F9Jl9XPkm4Zfnec4efv64X9zmd7-Xvxbf7_IglepzoayBGipEkIWylldKeW-9UaZagbahkhMiy0IbjSutLQclQiVq9NagqYtz9u3Y-zhUO6wDtn30jXuMtPNx7zpP7u2mpY1bd6PTXAsBeiq4fC6I3d8BU-92lAI2jW-xG5ITwoIprDXlhIojGmKXUsTV6xkO7qDcbd1BuTsod0flU-ji_wdfIy-OJ-D6COCkaSSMLgXCNmBNEUPv6o7e6_8HYgOS9A</recordid><startdate>20191015</startdate><enddate>20191015</enddate><creator>Baltina, Lidia A.</creator><creator>Tasi, Yan-Ting</creator><creator>Huang, Su-Hua</creator><creator>Lai, Hsueh-Chou</creator><creator>Baltina, Lia A.</creator><creator>Petrova, Svetlana F.</creator><creator>Yunusov, Marat S.</creator><creator>Lin, Cheng-Wen</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20191015</creationdate><title>Glycyrrhizic acid derivatives as Dengue virus inhibitors</title><author>Baltina, Lidia A. ; Tasi, Yan-Ting ; Huang, Su-Hua ; Lai, Hsueh-Chou ; Baltina, Lia A. ; Petrova, Svetlana F. ; Yunusov, Marat S. ; Lin, Cheng-Wen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-25980d0bee0435991b55aa9a858bf079cb4259463787ef7791052cb2dea98e8d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents - chemistry</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Antiviral activity</topic><topic>Antiviral Agents - chemistry</topic><topic>Antiviral Agents - pharmacology</topic><topic>Cell Survival - drug effects</topic><topic>Chlorocebus aethiops</topic><topic>Cytopathogenic Effect, Viral - drug effects</topic><topic>Dengue - drug therapy</topic><topic>Dengue virus</topic><topic>Dengue Virus - drug effects</topic><topic>Derivatives</topic><topic>Glycyrrhizic acid</topic><topic>Glycyrrhizic Acid - analogs & derivatives</topic><topic>Glycyrrhizic Acid - chemistry</topic><topic>Glycyrrhizic Acid - pharmacology</topic><topic>Humans</topic><topic>Molecular Structure</topic><topic>Small Molecule Libraries - chemistry</topic><topic>Small Molecule Libraries - pharmacology</topic><topic>Structure-Activity Relationship</topic><topic>Vero Cells - drug effects</topic><topic>Virus Replication - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baltina, Lidia A.</creatorcontrib><creatorcontrib>Tasi, Yan-Ting</creatorcontrib><creatorcontrib>Huang, Su-Hua</creatorcontrib><creatorcontrib>Lai, Hsueh-Chou</creatorcontrib><creatorcontrib>Baltina, Lia A.</creatorcontrib><creatorcontrib>Petrova, Svetlana F.</creatorcontrib><creatorcontrib>Yunusov, Marat S.</creatorcontrib><creatorcontrib>Lin, Cheng-Wen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baltina, Lidia A.</au><au>Tasi, Yan-Ting</au><au>Huang, Su-Hua</au><au>Lai, Hsueh-Chou</au><au>Baltina, Lia A.</au><au>Petrova, Svetlana F.</au><au>Yunusov, Marat S.</au><au>Lin, Cheng-Wen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glycyrrhizic acid derivatives as Dengue virus inhibitors</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2019-10-15</date><risdate>2019</risdate><volume>29</volume><issue>20</issue><spage>126645</spage><epage>126645</epage><pages>126645-126645</pages><artnum>126645</artnum><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>[Display omitted]
•It is the first report to display structure-anti-DENV activity relationships of Glycyrrhizic acid (GL) derivatives.•GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 have been identified as potent DENV2 inhibitors.•GL derivatives 13 and 17 showed lower IC50 values (1.2–1.3 μM) against DENV2 infectivity in Vero E6 cells than GL (IC50 8.1 μM).
Dengue virus (DENV) is one of the most geographically distributed pathogenic flaviviruses transmitted by mosquitoes Aedes sps. In this study, the structure-antiviral activity relationships of Glycyrrhizic acid (GL) derivatives was evaluated by the inhibitory assays on the cytopathic effect (CPE) and viral infectivity of DENV type 2 (DENV2) in Vero E6 cells. GL (96% purity) had a low cytotoxicity to Vero E6 cells, inhibited DENV2-induced CPE, and reduced the DENV-2 infectivity with the IC50 of 8.1 μM. Conjugation of GL with amino acids or their methyl esters and the introduction of aromatic acylhydrazide residues into the carbohydrate part strongly influenced on the antiviral activity. Among compounds tested GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 were found as potent anti-DENV2 inhibitors (IC50 1.2–1.3 μM). Therefore, modification of GL is a perspective way in the search of new antivirals against DENV2 infection.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>31519375</pmid><doi>10.1016/j.bmcl.2019.126645</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-894X |
ispartof | Bioorganic & medicinal chemistry letters, 2019-10, Vol.29 (20), p.126645-126645, Article 126645 |
issn | 0960-894X 1464-3405 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7172207 |
source | ScienceDirect Journals |
subjects | Animals Anti-Inflammatory Agents - chemistry Anti-Inflammatory Agents - pharmacology Antiviral activity Antiviral Agents - chemistry Antiviral Agents - pharmacology Cell Survival - drug effects Chlorocebus aethiops Cytopathogenic Effect, Viral - drug effects Dengue - drug therapy Dengue virus Dengue Virus - drug effects Derivatives Glycyrrhizic acid Glycyrrhizic Acid - analogs & derivatives Glycyrrhizic Acid - chemistry Glycyrrhizic Acid - pharmacology Humans Molecular Structure Small Molecule Libraries - chemistry Small Molecule Libraries - pharmacology Structure-Activity Relationship Vero Cells - drug effects Virus Replication - drug effects |
title | Glycyrrhizic acid derivatives as Dengue virus inhibitors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T08%3A38%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glycyrrhizic%20acid%20derivatives%20as%20Dengue%20virus%20inhibitors&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Baltina,%20Lidia%20A.&rft.date=2019-10-15&rft.volume=29&rft.issue=20&rft.spage=126645&rft.epage=126645&rft.pages=126645-126645&rft.artnum=126645&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2019.126645&rft_dat=%3Cproquest_pubme%3E2290839986%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-25980d0bee0435991b55aa9a858bf079cb4259463787ef7791052cb2dea98e8d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2290839986&rft_id=info:pmid/31519375&rfr_iscdi=true |